ARTIREM 0.0025 mmol/ml, solution for injection in a pre-filled syringe syringe, 20 ml
Active ingredients: Gadoteric acid, DOTA, Gadolinium(III) oxide
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 20 mlintraarticulaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ARTIREM 0,0025 mmol/mL, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- intraarticulaire
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 20 ml
- Marketing authorisation holder
- GUERBET
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Sept 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60314272CIP73599138CIP133400935991386Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OXYDE DE GADOLINIUMsolution | 0,453 mg · 1 ml de solution | SA |
| ACIDE GADOTÉRIQUEsolution | 1,397 mg · 1 ml de solution | FT |
| DOTAsolution | 1,012 mg · 1 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.